ABIOMED Stock News

These beaten-down growth stocks have significant upside.

U.S. stocks finished lower a day before the conclusion of a two-day Federal Reserve meeting and as the labor market shows little sign of slowing.

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 50 points on Tuesday. The Dow traded down 0.15% to 32,683.95 while the NASDAQ fell 0.55% to 10,927.54. The S&P 50

Buyer Poseidon Acquisition Corp. includes Atlas Corp.'s chairman as well as shipping company Ocean Network Express.

A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion.

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. Abiomed, Inc. (NASDAQ: ABMD) shares jumped 50.4%

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday. The Dow traded down 0.66% to 32,517.70 while the NASDAQ fell 0.86% to 10,894.04. The S&P 5

Marking its biggest deal in nearly six years, Johnson & Johnson ( JNJ , Financial) announced on Tuesday it is buying Abiomed Inc. ( ABMD , Financial) for $16.6 billion in a bid to boost its cardiovasc

Abiomed, Inc. (NASDAQ:ABMD ) Q2 2023 Earnings Conference Call November 1, 2022 8:00 AM ET Company Participants Jessica Moore - Vice President of Investor Relations, Johnson & Johnson. Joaquin Duato -

ABIOMED Inc (NASDAQ: ABMD) opened about 50% up on Tuesday after Johnson & Johnson (NYSE: JNJ) said it will buy the heart pump maker for $16.6 billion. ABIOMED stock shot up in line with the proposed p

Upgrades For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to Buy. AnaptysBio earned $1.15 in the second quarter, compared to $0.02 in the year-ago quarter. The sto

U.S. stocks traded lower this morning, with the Dow Jones dropping around 80 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.24% to 32,653.67 while the NASDAQ fell 0.24%

The deal would add heart pumps, a fast-growing part of the medical-device industry, to the J&J lineup.

Yahoo Finance anchor Julie Hyman reports the latest headlines including a Judge blocking Penguin-Simon & Schuster deal, Delta pilots calling for strike, J&J planning to buy Abiomed and the Supreme Cou

Earnings are only part of the story.